Business
Can Psychedelics Treat Alcoholism? New Psilocybin & DMT Studies Say YES Wakeful Travel Kickstarter: https://www.kickstarter.com/projects/920110985/wakeful-travel-journals-support-your-transformation?ref=f1y202 In today's episode, we dive...
This week in psychedelic business news: Compass Pathways files another patent; Seelos Therapeutics raises big money; Cybin makes psychedelic therapy...
In this episode, James, The Psychedelic Investor, sits down with Doug Drysdale, CEO of Cybin (NYSE: CYBN) for the Psychedelic...
The company is also exploring if ketamine can treat other neurological conditions, including Parkinson’s Disease, ALS, and CRPS....
A travel journal company pivots from external trips to those unfolding in the mind, and the psychedelic community is embracing...
Does Jon Stewart Microdosing Magic Mushrooms? Have you ever wanted to try microdosing magic mushrooms before, because Jon Stewart wants...
In today’s episode, we look at MindMed’s (Nasdaq: MNMD, NEO: MMED) Project Flow, which is their LSD microdosing division. At...
This week in psychedelic business news: Companies partner on new dosage method; MindMed investigates LSD microdosing; Health Canada allows a...
In today's episode, we discuss the results of the much awaited phase 2b clinical trial using psilocybin (comp360) to treat...
Analyzing the Quarter 3 financial results of atai Life Sciences (Nasdaq: ATAI), Compass Pathways (Nasdaq: CMPS), MindMed (Nasdaq: MNMD) and...